Form D filings with the SEC list Michael St Collins as an executive officer of AVSF - Arda Therapeutics 2024. See sector focus.
Form D filings with the SEC list Michael St Collins as an executive officer of AVSF - Arda Therapeutics 2024. One Form D filing is on record, which lists the offering AVSF - Arda Therapeutics 2024, LLC. This offering has a total amount of $575,000 and a minimum investment accepted of $10,000. The issuer's address on file is Manchester. The SEC industry group for this offering is Pooled Investment Fund.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Manchester.
Investors like Michael St Collins · Full investor directory · Investor access · Company funding database